TCAPS 37.5 micrograms, soft capsule 30 capsules
Active ingredients: Levothyroxine sodium, Levothyroxine sodium
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TCAPS 37,5 microgrammes, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polychlortrifluoroéthylène aluminium de 30 capsule(s)
- Marketing authorisation holder
- IBSA PHARMA SAS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60188119CIP73026697CIP133400930266977Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOTHYROXINE SODIQUEcapsule | — | SA |
| LÉVOTHYROXINE SODIQUE ANHYDREcapsule | 37,5 microgrammes · une capsule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.